SCHEMBL30879482

SCHEMBL30879482

COCOCc1ccc(Oc2ccc(OC)cc2)cc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.42
NAAA Q02083 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
PARP10 Q53GL7 1/20 0.33
HTR2A P28223 2/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL597187 0.91 NAAA (0.49) LTA4HNAAASMN1; SMN2ALDH1A1KDM4E
SCHEMBL595741 0.90 SLC6A4 (0.38) NAAAALDH1A1L3MBTL1HTR2ASLC6A2
SCHEMBL596000 0.86 NAAA (0.43) NAAAKDM4EMEN1KMT2APARP10
SCHEMBL596202 0.80 NAAA (0.43) NAAAALDH1A1HTR2APDE4APDE4B
SCHEMBL7865181 0.79 LTA4H (0.40) LTA4HSMN1; SMN2ALDH1A1KDM4EHTT
SCHEMBL595689 0.79 LTA4H (0.41) LTA4HNAAASMN1; SMN2ALDH1A1KDM4E
SCHEMBL500774 0.79 IDO1 (0.41) HTR2AHTR2CSLC6A4
SCHEMBL12806920 0.78 LTA4H (0.45) LTA4HNAAASMN1; SMN2ALDH1A1KDM4E
SCHEMBL18194091 0.78 SLC6A4 (0.37) ALDH1A1KMT2AHTR2APDE4APDE4B
SCHEMBL1134380 0.78 LTA4H (0.43) LTA4HNAAASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346549-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2025-11-13 US disclosed
US-20250084023-A2 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2025-03-13 US disclosed
US-20240140895-A1 NOVEL AROMATIC MOLECULES Xeniopro GmbH (DE) 2024-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084023-A2 NOVEL AROMATIC MOLECULES AHR, TYR, MUSK LTA4H 3460/4885NAAA 4529/4885SMN1; SMN2 1224/4885
US-20250346549-A2 NOVEL AROMATIC MOLECULES AHR, TYR, MUSK LTA4H 3460/4885NAAA 4529/4885SMN1; SMN2 1224/4885
US-20240140895-A1 NOVEL AROMATIC MOLECULES AHR, TYR, MUSK LTA4H 3460/4885NAAA 4529/4885SMN1; SMN2 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.